Merck asks FDA to authorize promising anti-COVID pill

Merck has asked U.S. regulators to authorize its pill against COVID-19 in what would add a new and easy-to-use weapon to the world's arsenal against the pandemic.

Related Keywords

United States ,Kenilworth ,District Of Columbia ,Washington ,Americans ,Ridgeback Biotherapeutic ,Nicholas Kartsonis ,Merck Kartsonis ,Pfizer ,Astrazeneca ,Drug Administration ,Drugmaker Merck ,New Jersey Based Merck ,Wire ,Dcc ,Ccjs ,Ation World ,Coronavirus ,Health Wellness ,Fda ,Treatment ,Medicine ,Harmacology ,Mmunology ,Hill ,Merck ,Drug ,Medication ,Ntibody ,